Outsourcing Pharmaceutical Manufacturing to India

Re-Publish this Article

<h1>Outsourcing Pharmaceutical Manufacturing to India</h1><strong> Author: <a href='http://www.articleseen.com/profile_Gunjan Kothia.aspx'>Gunjan Kothia</a></strong><br /><p>Did you know over 80% of bio-pharma respondents report increased alliance activity compared to five years ago? Over the past few years, India has been the up-and-coming destinations for international outsourcing of pharmaceutical manufacturing like Tyramine hydrochloride 60-19-5. Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organisations as a strategy to stay competitive and flexible in a world of exponentially growing knowledge. Research says, drug discovery outsourcing will continue to grow over the next decade and will rise to a 43.7 billion dollar industry by 2026. Outsourcing Pharmaceutical The companies in India, who were specialised in manufacturing, supplying, exporting drugs like CYCLOPROPANECARBONYL CHLORIDE 4023-34-1, analysis and exclusive content from thought leaders for the advancement of global outsourcing of drug development and manufacturing. The community in India will understand the relationships between pharmaceutical and biotechnology organisations with their service providers. Pros of Outsourcing Pharmaceutical in India Concerned with rising R&D costs, U.S. pharma companies are considering India for the development of their Active Pharmaceutical Ingredients (APIs) and pharma products to grow, outpacing that of Asia Pacific. This is because; drug intermediates manufacturer in India can provide cheap labour and low-cost production facilities. From a cost perspective, Indian manufacturers save companies 30 to 60% of the costs of manufacturing in the U.S. Below are some things to know about when considering manufacturing in India. Growth in Asian Pharma Markets On a pharmaceutical market annual growth assumption of 10% to 15% in Asia compared to between 5% and 7% a year in G7 territories, India would be in the top 10 in the pharmaceutical market in the world by 2020. India could grow to almost 90% of the size of the US by 2050. Such economic growth would create major pharmaceutical markets. Asian territories have led much of the growth with the number of trials taking place in China and India, in particular, growing fast as a result of recent moves to strengthen IPP laws. The cost has been a critical factor alongside IPP improvements. Clinical trials are estimated to be up to 50% cheaper in India, for example, compared to the US. India as one of the fastest growing locations for drug trials India can potentially save up to 60% on costs and reduce patient enrolment time by as much as 30%. The cost of clinical trials in India is about 50% less than in the US. Also, the labour costs are comparable to developed territories in the West and are significantly higher than those in India. </p><strong>About the Author:</strong><br />The author of this article is the leading manufacturer and exporter of drug intermediates like <a rel="nofollow" href="http://www.ganesh-group.com/products" target="_blank">CYCLOPROPANECARBONYL CHLORIDE</a> 4023-34-1. In this article, he discusses outsourcing pharmaceutical manufacturing to India. To know more, visit <a rel="nofollow" href="http://www.ganesh-group.com/" target="_blank">http://www.ganesh-group.com/</a><p> Article Source: <a href='http://www.articleseen.com/Article_Outsourcing-Pharmaceutical-Manufacturing-to-India_321855.aspx'> http://www.articleseen.com/Article_Outsourcing Pharmaceutical Manufacturing to India_321855.aspx</a></p>

Article Source : http://www.articleseen.com/Article_Outsourcing Pharmaceutical Manufacturing to India_321855.aspx

Keywords : Tyramine hydrochloride 60-19-5, CYCLOPROPANECARBONYL CHLORIDE, drug intermediates manufacturer in India,

Category : Business : Business